This informal CPD article ‘Understanding Aluminium in Vaccines: What the Largest Safety Study Ever Tells Us’ was provided by Cima Care, who offer extensive training in vaccination and public health, advancing global health initiatives.
"Is the aluminium in vaccines safe?" "Could it cause autism or allergies?" "Should I be worried about giving this to my baby?" These concerns about aluminium in childhood vaccines are often among the most common questions parents may ask. Uncertainty is understandable. Aluminium is a metal; it is in multiple vaccines, and conflicting information online can make it difficult to know what is true.
The good news is that the largest and most comprehensive study ever conducted on this topic has been completed, examining 1.2 million children over more than two decades. The findings provide reassuring answers. 1
What Are Aluminium Adjuvants, and Why Are They Used?
Aluminium compounds in vaccines serve a specific purpose. They are "adjuvants, which means they help vaccines work better. Think of them as helpers that boost your immune system's response to the vaccine. Scientists have been using aluminium adjuvants in vaccines since the 1920s, when researchers discovered that adding aluminium to vaccines for diphtheria and tetanus made them far more effective. Here is how they work:
They help concentrate the vaccine ingredients at the injection site, making it easier for your immune cells to find and respond to them. Moreover, they reduce the amount of antigen needed per dose, meaning that without aluminium adjuvants, many vaccines would require larger doses or be less effective.
Additionally, they activate specific parts of your immune system, triggering a stronger and longer-lasting protective response. Finally, they help vaccines produce higher levels of antibodies, the proteins that protect you from disease. 13 & 14
The Largest Aluminium Vaccine Safety Study Ever Conducted
In 2025, researchers published what many experts have called the most definitive study on aluminium vaccine safety ever undertaken:
The study tracked 1,224,176 children born between 1997 and 2018; that is, over 1.2 million children were followed for more than two decades. This scale makes the findings particularly reliable.
Vaccination schedule in the region changed several times during this period, meaning different children received different amounts of aluminium from vaccines, ranging from 0 to 4.5 milligrams in their first 2 years of life. This natural variation created a perfect opportunity to compare health outcomes.
The researchers examined 50 different chronic health conditions, including:
- 36 autoimmune conditions (like juvenile arthritis, celiac disease, and thyroid disorders)
- 9 allergic or atopic disorders (like asthma, eczema, and food allergies)
- 5 neurodevelopmental conditions (including autism and ADHD). 1 & 2
The Surprising Findings
When researchers compared children who received different amounts of aluminium from vaccines, here is what they found:
For every extra milligram of aluminium a child received from vaccines:
- There was a 2% lower rate of autoimmune diseases.
- There was a 1% lower rate of allergic conditions.
- There was a 7% lower rate of neurodevelopmental disorders.
In other words, children who received more aluminium from vaccines actually had slightly lower rates of these conditions, and not higher rates. But before you conclude that aluminium is protective, it is important to understand that this pattern likely reflects other factors, such as children with better healthcare access receiving more complete vaccination schedules. The key finding is not that aluminium protects health, but rather that it clearly does not cause harm. 1
To be more transparent, a likely explanation for these small decreases is that the children who follow the full recommended vaccination schedule tend to come from families with more consistent engagement with the health system, higher rates of well‑child visits, and better overall preventive care, which are all associated with improved health outcomes and earlier detection and management of conditions.
In addition, parents who accept all recommended vaccines may differ from vaccine‑hesitant parents in factors such as education, income, health literacy, and trust in medical advice, and these “healthy user” or “confounding by indication” effects can make fully vaccinated children appear slightly healthier in observational studies even when the vaccines (or aluminium) are not directly causing the difference. 15-19
Understanding these Findings
The researchers used sophisticated statistical methods to determine how confident they could be in their results:
In this very large study of more than 1.2 million children, researchers looked for links between aluminium in vaccines and a wide range of long‑term health problems, including autism, asthma, allergies, autoimmune diseases, ADHD, eczema, juvenile arthritis, and many others. Across all 50 chronic conditions they examined, they found no statistically significant increase in risk in children who received more aluminium‑containing vaccines compared with those who received fewer, meaning the data were strong enough to rule out any meaningful increase in risk for these conditions from aluminium exposure in childhood vaccines.
The study's massive size, 1.2 million children, and rigorous methods make these findings particularly reassuring. As one prominent vaccine safety scientist noted, this is "the largest and most definitive observational study on the safety of vaccine-related aluminium exposure in children ever conducted." 1 & 2
All exposed to aluminium through food and water
How Much Aluminium Are We Actually Talking About?
To put vaccine aluminium exposure in perspective, it helps to understand that we are all exposed to aluminium daily through food and water. The amounts in vaccines are carefully controlled and remarkably small. In fact, in the first six months of life, infants receive approximately 4.4 milligrams of aluminium from all recommended vaccines combined. 6
By comparison, during the same period:
- Breastfed babies consume about 7 milligrams of aluminium from breast milk.
- Formula-fed babies consume approximately 38 milligrams from formula.
- Studies using specially labelled aluminium molecules show that aluminium from vaccines is primarily deposited in bone tissue and remains well below established safety thresholds.
- The body eliminates aluminium efficiently, keeping exposure levels far below levels that could cause harm. 6 & 7
What Do Major Health Organisations Say?
Every major health organisation worldwide has reviewed the evidence on aluminium adjuvant safety and:
- They continue to support the use of aluminium adjuvants based on comprehensive risk assessments spanning over 70 years of clinical experience. 3
- They confirm that aluminium salts have been used safely in vaccines for seven decades, with extensive monitoring data supporting their continued use. 4
- They classify aluminium adjuvants as well-established compounds with demonstrated safety across multiple vaccine formulations. 5
- They confirm that the quantity of aluminium in approved vaccines is minimal and rigorously tested, with total exposure remaining far below safety thresholds even for young or medically vulnerable children. 11
Why Do Concerns About Aluminium Persist?
Despite overwhelming scientific evidence supporting aluminium adjuvant safety, concerns continue to grow. For instance, an investigation shows that the percentage of parents in the region of the research who are "really against" childhood vaccinations increased from about 4% in 2019 to 17% in 2024, a fourfold increase in just five years. Concerns about aluminium in vaccines may contribute to this hesitancy. 8
This gap between scientific evidence and public concern highlights important challenges:
Healthcare providers often find it difficult to communicate complex safety evidence effectively, with over one-third reporting they feel uncomfortable counselling vaccine-hesitant patients. Some communication approaches, like aggressive "myth-busting" or fear-based messaging, may inadvertently increase familiarity with misinformation rather than dispelling it. 9
Research suggests that more effective approaches include empathetic listening, providing contextual comparisons (such as breast milk vs. vaccine aluminium), and addressing each person's specific concerns rather than using one-size-fits-all messaging. 10
What We Still Don't Fully Understand
Researchers identified several areas requiring further study: how aluminium behaves in the body over very long periods, whether individuals differ in how they process aluminium, and how aluminium affects special populations, such as premature infants. However, these knowledge gaps relate to understanding mechanisms rather than safety concerns, and decades of use have demonstrated that aluminium adjuvants are safe in practice. 12
Key Takeaways
- Aluminium adjuvants help vaccines work better by boosting the immune system's response.
- The largest safety study ever conducted—tracking 1.2 million children over 21 years—found no increased health risks from aluminium in vaccines.
- Aluminium exposure from vaccines is smaller than from breast milk or formula feeding.
- All major health organisations worldwide support the safety of aluminium adjuvants based on decades of evidence.
- While some knowledge gaps remain regarding the precise mechanisms, the safety profile is well established through extensive real-world use. 1-14
Making Informed Decisions
Understanding vaccine ingredients helps you make informed decisions about your family's health. The evidence on aluminium adjuvants is now increasingly clear and reassuring, backed by the largest safety study ever conducted and confirmed by health organisations worldwide.
However, if you have specific concerns about aluminium in vaccines, discussing them with your healthcare provider is important. They can provide personalised information based on your family's circumstances and help you weigh the well-documented benefits of vaccination against the very small and well-characterised amounts of aluminium used to make vaccines effective.
We hope this article was helpful. For more information from Cima Care, please visit their CPD Member Directory page. Alternatively, you can go to the CPD Industry Hubs for more articles, courses and events relevant to your Continuing Professional Development requirements.
REFERENCES
1- Andersson, N.W., Svalgaard, I.B., Hoffmann, S.S., & Hviid, A. (2025). Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study. Annals of Internal Medicine. https://doi.org/10.7326/ANNALS-25-00997
2- Major new study finds no health risks from aluminium in childhood vaccines [Internet]. Gavi.org. 2025 [cited 2025 Aug 27]. Available from: https://www.gavi.org/vaccineswork/major-new-study-finds-no-health-risks-aluminium-childhood-vaccines
3- Adjuvants [Internet]. www.who.int. Available from: https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/adjuvants
4- CDC. Adjuvants and Vaccines [Internet]. Vaccine Safety. 2024. Available from: https://www.cdc.gov/vaccine-safety/about/adjuvants.html
5- Adjuvants in vaccines for human use - Scientific guideline | European Medicines Agency (EMA) [Internet]. European Medicines Agency (EMA). 2005 [cited 2025 Aug 27]. Available from: https://www.ema.europa.eu/en/adjuvants-vaccines-human-use-scientific-guideline
6- Vaccine Ingredients: Aluminum [Internet]. Chop.edu. 2022. Available from: https://www.chop.edu/vaccine-education-center/vaccine-safety/vaccine-ingredients/aluminum
7- Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO. Updated aluminum pharmacokinetics following infant exposures through diet and vaccination. Vaccine [Internet]. 2011 Nov 28;29(51):9538–43. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22001122
8- Korzinski D. Parental opposition to childhood vaccination grows as Canadians worry about harms of anti-vax movement [Internet]. Angus Reid Institute. 2024. Available from: https://angusreid.org/canada-vaccines-childhood-vaccinations-anti-vax-mandates-covid-19-flu-mmr-side-effects/
9- Löffler P. Review: Vaccine Myth-Buster – Cleaning Up With Prejudices and Dangerous Misinformation. Frontiers in Immunology. 2021 Jun 10;12.
10- Aluminum Adjuvants Talking Points [Internet]. Association of Immunization Managers. 2022. Available from: https://www.immunizationmanagers.org/resources/aluminum-adjuvants-talking-points/
11- Center for Biologics Evaluation and Research. Common Ingredients in FDA-Approved Vaccines. FDA [Internet]. 2024 Jan 12; Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/common-ingredients-fda-approved-vaccines
12- Francisco H. News-Medical [Internet]. News-Medical. 2025 [cited 2025 Aug 28]. Available from: https://www.news-medical.net/health/Aluminum-in-Vaccines-Mechanisms-Myths-and-Safety-Data.aspx
13- Xing J, Zhao X, Li X, Fang R, Sun M, Zhang Y, et al. The recent advances in vaccine adjuvants. Frontiers in Immunology. 2025 May 13;16.
14- Lan J, Feng D, He X, Zhang Q, Zhang R. Basic Properties and Development Status of Aluminum Adjuvants Used for Vaccines. Vaccines. 2024 Oct 18;12(10):1187.
15- Does Education Really Make People More Pro-Vaccine? What the Research Shows [Internet]. Historyofvaccines.org. 2025. Available from: https://historyofvaccines.org/blog/does-education-really-make-people-more-pro-vaccine-what-research-shows
16- Zheng Y, Frew PM, Wang D, Eiden AL. Factors associated with parental literacy and hesitancy toward pediatric vaccination. BMC Public Health. 2025 Jul 2;25(1).
17- Zhang E, Dai Z, Wang S, Wang X, Zhang X, Fang Q. Vaccine Literacy and Vaccination: A Systematic Review. International Journal of Public Health [Internet]. 2023;68:1605606. Available from: https://pubmed.ncbi.nlm.nih.gov/36866001/
18- Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, et al. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule. Academic Pediatrics. 2018 Sep;18(7):754–62.
19- CDC. Biases to Consider in Vaccine Effectiveness Studies [Internet]. Flu Vaccines Work. 2024. Available from: https://www.cdc.gov/flu-vaccines-work/php/effectivenessqa/biases-to-consider.html
